Clinicians, investors, and operators — investing personally in the future of eye care.
We have spent our careers at the intersection of clinical medicine, company building, and early-stage investing in ophthalmology. We invest personally in every opportunity we bring to the group.
Domain expertise,
personally committed.

John S. Pollack, MD
Retina specialist and serial founder across data analytics, devices, and ocular health — including Vestrum Health (acq. 2021). Former President of the American Society of Retina Specialists.
View full bio →
Firas Rahhal, MD
Vitreoretinal specialist in active practice, Associate Clinical Professor at UCLA Geffen School of Medicine, and founding partner at ExSight Ventures. PI on 100+ ophthalmology clinical trials.
View full bio →
Michael Nissen, MD
Vitreoretinal surgeon, Weill Cornell faculty member since 1998, and co-founder at ExSight Ventures. Founder and director of the Insight Foundation for global ophthalmic education.
View full bio →
James Murray, JD
Venture investor and co-founder at ExSight Ventures, leading early-stage ophthalmic investments across the lifecycle. Board member at Re-Vana Therapeutics and the Usher III Initiative.
View full bio →Ready to take the next step?
If reading about our team has sparked your interest in EyeSci Angels, we would welcome the conversation. No obligation, no pressure — simply an opportunity to get acquainted.